The upcoming #virtual Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies program on Sept. 11, features authorities in cancer immunotherapy. Address toxicities beyond CRS and ICANS. Register now: https://t.co/Boa0Lmc1d6 @MJFzeta @rncusatis @LoriMuffly

TOPcast ep130 includes shoutouts to @tjoosten @DETAResearch @UWM @rncusatis @katrinamwehr @YESPLZdotCOFFEE and more!

One of our top ten articles this month: @rncusatis in @AjHematology on Health-related quality of life in reduced intensity HSCT based on donor availability in patients aged 50-75 with advanced #MDS https://t.co/tELr9X548A #BMT #StemCellEvidence

@DETAResearch @rncusatis @LindseyHarness Read the article and download the infographic on @DETAResearch's new site, https://t.co/8CHyX7m8To.

3rd Health Services Oral: CAR-T Recipients & Worsening Financial Impact over Time: A Mixed Methods Longitudinal Study by @rncusatis & coauthors @CIBMTR @MedicalCollege @StanfordBMT_CT https://t.co/j33VdlfZyw

Looking forward to hearing various perspectives from #BMTCTN 1102 study Co-Chair @DrCCutler, #BMTCTN Evidence into Practice members Drs. Chandra & Kindwall-Keller & #BMTCTN QOL Cmte member @rncusatis Thanks @BeTheMatch for offering this session to highlight the study findings!

One of our current top ten articles: Adding centralized electronic patient-reported outcome (PRO) data collection to an established international clinical outcomes registry. @rncusatis et al in @ASTCT_Journal https://t.co/HGGYvkyxfM #BMT #StemCellEvidence

🙏 @SurbhiSidanaMD @adsouza_md et al for addressing important #ASH21 topic: financial toxicity with #TcellRx. SW colleagues are EXCELLENT at supporting pts leading into CAR-T therapy, but more work needed on other side. CAR-T outcomes: Achieving MRD-neg 👍, creating GoFundMe 👎

#ASH21 Financial toxicity with CAR-T therapy, excellent presentation by @rncusatis! @LoriMuffly @StanfordBMT_CT - Increasing FT with time -Lodging, travel, insurance coverage, need to give up other things are common themes

Not surprisingly, patients experience financial toxicity following #CARTcell #CellTherapy as presented by @rncusatis at #ASH21. Their qualitative data highlight the need for additional support for lodging and relocation in order to ensure #accesstocare @LoriMuffly @adsouza_md

Worsening Financial Toxicity Among Pts Receiving CAR-T: Longitudinal Study ➡️ COST-FACIT scores highest @ baseline: indicates higher financial well-being; large range suggests pts come into CAR-T at different levels of financial tox. ➡️ Financial well-being declined over time

#ASH21 #cartsm Coming up shortly: Our work on financial toxicity in pts undergoing CAR-T therapy. Joint study at @StanfordBMT_CT and MCW. Will be presented by Dr Cusatis.

Attending #ASH21? CIBMTR investigators will present >30 abstracts, this weekend. Take a look at today’s abstract presentations below and see the full list on our website! https://t.co/vUWT61oVjL

If you are attending #ASH21 don't forget to check out #BMTCTN abstract presentations!

Qualitative methods, mixed methods, quantitative methods.

Check out the new DETA Update | March 2021 - https://t.co/ggAuoMGVc1 | Topics included equity and bias, COVID-19 research resources, and upcoming events and conferences.

Just got student evals back from last semester and I definitely shed some happy tears from their kind words... "Online is hard, but Dr. Cusatis made it work" 🥲

Just replace ‘one sentence’ with ‘one bullet point in a preso’...#same. 🙋🏻‍♀️

👻

Congrats to Dr Colin Johnson on his presentation on 6 year follow up of fertility patients’ regret surrounding fertility treatments! @mcwobgyn @ReprodMed #ASRM2020 @Jayman0827 @rncusatis